GLOBALT Investments LLC has filed its 13F-HR report with the SEC, detailing its investment holdings as of September 30, 2026. This filing is crucial for understanding the firm’s investment strategy and its positions in various sectors.

GLOBALT Investments LLC, based in Atlanta, Georgia, operates within the financial services sector. The firm is categorized under the SEC's other entity type and has been active in the investment management space, making strategic investments in a range of companies. The latest filing, dated October 27, 2026, follows a series of reports, including previous 13F filings and proxy voting records.

The filing reveals that GLOBALT Investments holds significant positions in several well-known companies. For instance, the firm reported holdings in Abbott Laboratories, AbbVie Inc, and Amazon.com Inc, among others. The total value of the reported holdings amounts to approximately $2.9 billion, indicating a robust investment strategy.

"The total value of the reported holdings amounts to approximately $2.9 billion, indicating a robust investment strategy."

These investments reflect GLOBALT’s focus on established companies within various industries, including healthcare, technology, and consumer goods. The firm’s decision to invest heavily in these sectors suggests a strategic approach to capital allocation, aiming to capitalize on growth opportunities in the market.

This update may impact various stakeholders, including investors, analysts, and competitors in the financial services sector. By disclosing its holdings, GLOBALT provides insights into its investment philosophy, which may influence market trends and investor sentiment.

Looking ahead, it remains to be seen how GLOBALT will adjust its investment strategy in response to market conditions. The filing does not specify any future actions or upcoming votes, leaving stakeholders to speculate on the firm’s next moves.